These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


231 related items for PubMed ID: 2413894

  • 1. Plasminogen activation and regulation of pericellular proteolysis.
    Saksela O.
    Biochim Biophys Acta; 1985 Nov 12; 823(1):35-65. PubMed ID: 2413894
    [No Abstract] [Full Text] [Related]

  • 2. Minactivin: a human monocyte product which specifically inactivates urokinase-type plasminogen activators.
    Golder JP, Stephens RW.
    Eur J Biochem; 1983 Nov 15; 136(3):517-22. PubMed ID: 6416839
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Interfering factors in the assay of plasminogen activators by the fibrin plate method. Occurrence of different inhibitors against tissue plasminogen activator and urokinase.
    Wijngaards G.
    Thromb Haemost; 1979 May 25; 41(3):590-600. PubMed ID: 111368
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cultured granulosa cells produce two plasminogen activators and an antiactivator, each regulated differently by gonadotropins.
    Ny T, Bjersing L, Hsueh AJ, Loskutoff DJ.
    Endocrinology; 1985 Apr 25; 116(4):1666-8. PubMed ID: 3918858
    [Abstract] [Full Text] [Related]

  • 9. Plasminogen activation in healing human wounds.
    Schäfer BM, Maier K, Eickhoff U, Todd RF, Kramer MD.
    Am J Pathol; 1994 Jun 25; 144(6):1269-80. PubMed ID: 8203466
    [Abstract] [Full Text] [Related]

  • 10. [Plasminogen activators and their physiological role].
    Andreenko GV.
    Ukr Biokhim Zh (1978); 1983 Jun 25; 55(3):329-43. PubMed ID: 6346623
    [No Abstract] [Full Text] [Related]

  • 11. Purification of a plasminogen activator inhibitor indistinguishable from alpha1-antitrypsin and an urokinase inhibitor in pregnancy plasma.
    Clemmensen I, Thorsen S, Müllertz S.
    Haemostasis; 1976 Jun 25; 5(4):218-30. PubMed ID: 826461
    [Abstract] [Full Text] [Related]

  • 12. Interaction of plasminogen activators and inhibitors with plasminogen and fibrin.
    Lijnen HR, Collen D.
    Semin Thromb Hemost; 1982 Jan 25; 8(1):2-10. PubMed ID: 6460318
    [No Abstract] [Full Text] [Related]

  • 13. Microplate immunocapture assay for plasminogen activators and their specific inhibitors.
    Stephens R, Leung KC, Pöllänen J, Salonen EM, Vaheri A.
    J Immunol Methods; 1987 Dec 24; 105(2):245-51. PubMed ID: 3121752
    [Abstract] [Full Text] [Related]

  • 14. [Plasminogen activators in tumor tissue].
    Tomasiuk R, Mirowski M, Wierzbicki R.
    Pol Arch Med Wewn; 1989 Jun 24; 81(6):355-63. PubMed ID: 2517455
    [No Abstract] [Full Text] [Related]

  • 15. [Enzymatic determination of plasminogen activators].
    Fischer BE.
    Z Med Lab Diagn; 1988 Jun 24; 29(6):327-32. PubMed ID: 2973186
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tissue plasminogen activator: chemical and physiological aspects.
    Bachmann F, Kruithof IE.
    Semin Thromb Hemost; 1984 Jan 24; 10(1):6-17. PubMed ID: 6422555
    [No Abstract] [Full Text] [Related]

  • 19. [Recent progress in fibrinolytic mechanism].
    Yasukouchi T.
    Rinsho Byori; 1986 Mar 24; 34(3):235-46. PubMed ID: 3086600
    [No Abstract] [Full Text] [Related]

  • 20. Properties of a partially purified preparation of a circulating plasminogen activator.
    Ogston D, Bennett B, Mackie M.
    Thromb Res; 1976 Mar 24; 8(3):275-84. PubMed ID: 131386
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.